C3orf38_4930453N24Rik Inhibitors belong to a highly specialized class of chemical compounds designed to interact with and modulate the activity of the C3orf38 and 4930453N24Rik proteins within biological systems. These proteins, encoded by the respective genes C3orf38 and 4930453N24Rik, represent lesser-known members of the human genome with limited characterized functions. The development and study of inhibitors targeting C3orf38 and 4930453N24Rik are rooted in the quest to unravel the biological roles and significance of these enigmatic proteins.
C3orf38_4930453N24Rik Inhibitors are engineered to selectively target C3orf38 and 4930453N24Rik, either by directly binding to the proteins or by interfering with their functional mechanisms, with the aim of investigating specific cellular processes associated with these proteins. As researchers delve into the molecular and cellular functions of these proteins, their inhibitors offer valuable tools to elucidate their roles in various biological contexts, such as cell differentiation, signal transduction, or cellular responses to environmental cues.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
A CDK inhibitor that can impact the cell cycle and transcriptional regulation, potentially affecting C3orf38 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
As a proteasome inhibitor, MG-132 might impact protein turnover, potentially influencing C3orf38 stability or expression. | ||||||